Last updated on March 2019

Women with Cutaneous Lupus Erythematosus (CLE)


Brief description of study

Women with Cutaneous Lupus Erythematosus (CLE)

Detailed Study Description

A research study is evaluating an investigational medication for cutaneous lupus erythematosus (CLE), or lupus-specific skin lesions, in women.

This research study may be an option if you:

  • Are a female 18-75 years of age
  • Have been diagnosed with moderate to severe CLE
  • Have had an inadequate response or intolerance to prior treatment for CLE

Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study medication at no cost.

Clinical Study Identifier: TX150788

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.